Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Avogaro

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Minerva Anestesiologica|July 1, 1981
[Preliminary clinical results with fructose-1,6-diphosphate in patients with hyperinsulinism]P Avogaro, G Bittolo Bon, M Pais
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1980
Zonal rotor ultracentrifugation: a proposal for improving the effectiveness of the procedureG Cazzolato, G Bittolo Bon, P Avogaro
Pharmacological Research Communications|February 1, 1978
Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administrationP Avogaro, G Bittolo-Bon, G Cazzolato
Lancet (London, England)|June 6, 1981
Need for new classification of lipoprotein derangements in human atherosclerosisP Avogaro, G B Bon, G Cazzolato
Free Radical Biology & Medicine|January 1, 1991
Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLCG Cazzolato, P Avogaro, G Bittolo-Bon
La Clinica Terapeutica|July 15, 1981
[Long-term effects of a glycosaminoglycan on plasma lipids]P Avogaro, G Bittolo-Bon, P Alessandrini
Pharmacological Research Communications|July 1, 1983
Effect of the compound "chloridarol" on plasma lipids and apolipoprotein levelsP Avogaro, C Bittolo Bon, M Fusello
Pharmacological Research|May 1, 1994
Probucol protects low-density lipoproteins from in vitro and in vivo oxidationG Bittolo-Bon, G Cazzolato, P Avogaro
Arteriosclerosis (Dallas, Tex.)|January 1, 1985
Apoprotein B-48 is a constant finding in very low density lipoproteins of humansG Cazzolato, G Bittolo Bon, P Avogaro
Atherosclerosis|February 1, 1988
A question concerning apo B-48P Avogaro, G Cazzolato, G Bittolo Bon
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Minerva Anestesiologica|July 1, 1981
[Preliminary clinical results with fructose-1,6-diphosphate in patients with hyperinsulinism]P Avogaro, G Bittolo Bon, M Pais
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1980
Zonal rotor ultracentrifugation: a proposal for improving the effectiveness of the procedureG Cazzolato, G Bittolo Bon, P Avogaro
Pharmacological Research Communications|February 1, 1978
Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administrationP Avogaro, G Bittolo-Bon, G Cazzolato
Lancet (London, England)|June 6, 1981
Need for new classification of lipoprotein derangements in human atherosclerosisP Avogaro, G B Bon, G Cazzolato
Free Radical Biology & Medicine|January 1, 1991
Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLCG Cazzolato, P Avogaro, G Bittolo-Bon
La Clinica Terapeutica|July 15, 1981
[Long-term effects of a glycosaminoglycan on plasma lipids]P Avogaro, G Bittolo-Bon, P Alessandrini
Pharmacological Research Communications|July 1, 1983
Effect of the compound "chloridarol" on plasma lipids and apolipoprotein levelsP Avogaro, C Bittolo Bon, M Fusello
Pharmacological Research|May 1, 1994
Probucol protects low-density lipoproteins from in vitro and in vivo oxidationG Bittolo-Bon, G Cazzolato, P Avogaro
Arteriosclerosis (Dallas, Tex.)|January 1, 1985
Apoprotein B-48 is a constant finding in very low density lipoproteins of humansG Cazzolato, G Bittolo Bon, P Avogaro
Atherosclerosis|February 1, 1988
A question concerning apo B-48P Avogaro, G Cazzolato, G Bittolo Bon
Pageof 9